CEBPα is a fundamental lineage-specific transcription factor that encourages the gene expression necessary for the differentiation and growth of myeloid progenitors.61, 62CEBPα mutations are recognized in about 10 to 15% of all cases of AML including CN-AML. Here, CEBPA is linked to acute myeloid leukemia.